Literature DB >> 8372048

Pharmacokinetics of trazodone during multiple dosing to psychiatric patients.

O G Nilsen1, O Dale, B Husebø.   

Abstract

Steady-state pharmacokinetics of trazodone were investigated over a period of 4 weeks in seven psychiatric patients after repeated oral administrations of 50, 100, and 150 mg twice daily for one, one, and two consecutive weeks, respectively. Unchanged trazodone was determined by high performance liquid chromatography after a basic extraction. A steady-state level of serum trazodone was achieved for the 50 mg dose within 36 hr, while a new steady state level after increasing the dose to 100 mg and then 150 mg twice daily apparently was achieved at 12 hr. Trazodone showed linear pharmacokinetics within the dosage range investigated. The following main parameters were calculated at steady state for psychiatric patients (mean +/- S.D.): t 1/2 = 7.0 +/- 1.2, V beta/F = 0.50 +/- 0.13 l/kg and Clt/F = 3.2 +/- 0.5 l/hr. These pharmacokinetic parameters did not differ significantly from those earlier reported in healthy subjects after a single dose administration of 100 mg when based on an oral availability of trazodone of 65%.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372048     DOI: 10.1111/j.1600-0773.1993.tb01651.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  6 in total

Review 1.  Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine.

Authors:  S Rotzinger; M Bourin; Y Akimoto; R T Coutts; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 2.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 3.  Pharmacokinetics of antidepressants in patients with hepatic impairment.

Authors:  Massimo Carlo Mauri; Alessio Fiorentini; Silvia Paletta; Alfredo Carlo Altamura
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

4.  Estimation of an Appropriate Dose of Trazodone for Pediatric Insomnia and the Potential for a Trazodone-Atomoxetine Interaction.

Authors:  Laura Oggianu; Alice B Ke; Manoranjenni Chetty; Rossella Picollo; Vanessa Petrucci; Fabrizio Calisti; Fabio Garofolo; Serena Tongiani
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-01-11

5.  Effect of 3 Single Doses of Trazodone on QTc Interval in Healthy Subjects.

Authors:  Valeria Tellone; Maria Teresa Rosignoli; Rossella Picollo; Patrizia Dragone; Alessandra Del Vecchio; Alessandro Comandini; Milko Radicioni; Chiara Leuratti; Fabrizio Calisti
Journal:  J Clin Pharmacol       Date:  2020-06-02       Impact factor: 3.126

6.  Tinnitus treatment with Trazodone.

Authors:  Gabriel Cesar Dib; Cristiane Akemi Kasse; Tatiana Alves de Andrade; José Ricardo Gurgel Testa; Oswaldo Laércio M Cruz
Journal:  Braz J Otorhinolaryngol       Date:  2007 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.